APA (7th ed.) Citation

N, J., E, J., M, S., L, B., RA, L., T, O., . . . K, D. (2022). Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial. Leukemia, 36(9), 2218. https://doi.org/10.1038/s41375-022-01650-w

Chicago Style (17th ed.) Citation

N, Jahn, et al. "Genomic Landscape of Patients with FLT3-mutated Acute Myeloid Leukemia (AML) Treated Within the CALGB 10603/RATIFY Trial." Leukemia 36, no. 9 (2022): 2218. https://doi.org/10.1038/s41375-022-01650-w.

MLA (9th ed.) Citation

N, Jahn, et al. "Genomic Landscape of Patients with FLT3-mutated Acute Myeloid Leukemia (AML) Treated Within the CALGB 10603/RATIFY Trial." Leukemia, vol. 36, no. 9, 2022, p. 2218, https://doi.org/10.1038/s41375-022-01650-w.